1.22
price down icon0.41%   -0.01
 
loading
Schlusskurs vom Vortag:
$1.23
Offen:
$1.23
24-Stunden-Volumen:
432.11K
Relative Volume:
0.29
Marktkapitalisierung:
$284.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-0.9173
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
-11.23%
1M Leistung:
+10.36%
6M Leistung:
+35.42%
1J Leistung:
+29.27%
1-Tages-Spanne:
Value
$1.195
$1.245
1-Wochen-Bereich:
Value
$1.195
$1.385
52-Wochen-Spanne:
Value
$0.6617
$1.55

Gossamer Bio Inc Stock (GOSS) Company Profile

Name
Firmenname
Gossamer Bio Inc
Name
Telefon
(858) 684-1300
Name
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Name
Mitarbeiter
145
Name
Twitter
@GossamerBio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GOSS's Discussions on Twitter

Vergleichen Sie GOSS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GOSS
Gossamer Bio Inc
1.225 284.13M 0 -179.82M -159.16M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.22 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.79 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.49 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.53 28.51B 3.81B -644.79M -669.77M -6.24

Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-25 Eingeleitet Oppenheimer Outperform
2024-04-05 Fortgesetzt Wedbush Outperform
2023-07-27 Herabstufung UBS Buy → Neutral
2023-03-07 Herabstufung Raymond James Outperform → Mkt Perform
2023-03-01 Eingeleitet Guggenheim Neutral
2022-12-07 Herabstufung Barclays Overweight → Equal Weight
2022-12-07 Herabstufung JP Morgan Neutral → Underweight
2022-12-07 Herabstufung SMBC Nikko Outperform → Neutral
2022-10-20 Eingeleitet Goldman Buy
2022-09-21 Eingeleitet JP Morgan Neutral
2022-09-19 Eingeleitet Wedbush Outperform
2022-04-18 Eingeleitet Raymond James Outperform
2022-04-06 Eingeleitet UBS Buy
2022-01-10 Hochstufung SMBC Nikko Neutral → Outperform
2021-11-09 Fortgesetzt Cantor Fitzgerald Overweight
2021-09-21 Fortgesetzt Piper Sandler Overweight
2020-06-29 Eingeleitet H.C. Wainwright Buy
2020-04-22 Eingeleitet Piper Sandler Overweight
2020-02-27 Eingeleitet Barclays Overweight
2019-12-03 Fortgesetzt BofA/Merrill Buy
2019-10-30 Eingeleitet Berenberg Buy
2019-03-05 Eingeleitet Barclays Overweight
2019-03-05 Eingeleitet BofA/Merrill Buy
2019-03-05 Eingeleitet Evercore ISI Outperform
2019-03-05 Eingeleitet SVB Leerink Outperform
Alle ansehen

Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten

pulisher
Jun 16, 2025

Gossamer Bio Announces Completion of Enrollment in Registrationa - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Gossamer Bio (GOSS) Wraps Up Enrollment for Phase 3 PAH Study | GOSS Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Gossamer Bio Announces Completion Of Enrollment In Registrational Phase 3 PROSERA Study For The Treatment Of PAH - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH - New Castle News

Jun 16, 2025
pulisher
Jun 16, 2025

Gossamer Bio's Breakthrough PAH Drug Hits Major Milestone: 390 Patients Enrolled in Phase 3 Trial - Stock Titan

Jun 16, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Has $65,000 Stake in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Offer Predictions for Gossamer Bio FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Raises Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | GOSS Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 06, 2025
pulisher
May 26, 2025

HC Wainwright Increases Earnings Estimates for Gossamer Bio - Defense World

May 26, 2025
pulisher
May 22, 2025

Cantor Fitzgerald Forecasts Gossamer Bio FY2025 Earnings - Defense World

May 22, 2025
pulisher
May 20, 2025

Analyze Gossamer Bio Inc (NASDAQ: GOSS) Before Investing. - Stocksregister

May 20, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Has $59,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

May 19, 2025
pulisher
May 18, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript - MSN

May 18, 2025
pulisher
May 18, 2025

Wedbush Reiterates “Outperform” Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World

May 18, 2025
pulisher
May 18, 2025

The Goldman Sachs Group Raises Gossamer Bio (NASDAQ:GOSS) Price Target to $8.00 - Defense World

May 18, 2025
pulisher
May 17, 2025

GOSS Stock Update: Analyst Reiterates Outperform Rating | GOSS S - GuruFocus

May 17, 2025
pulisher
May 16, 2025

Gossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio (GOSS): Goldman Sachs Raises Price Target to $8.00 - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock - Investing.com

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ... - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strate - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Transcript : Gossamer Bio, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio earnings beat by $0.03, revenue topped estimates - Investing.com

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings: EPS Loss of $0.16 Beats Estimate, Revenue Surges to $9.9 Million - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GOSSAMER BIO Earnings Results: $GOSS Reports Quarterly Earnings - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key St - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key Studies | GOSS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study - Eagle-Tribune

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio Q1 2025 Earnings Call Transcript - MarketBeat

May 15, 2025
pulisher
May 14, 2025

What To Expect From Gossamer Bio Inc (GOSS) Q1 2025 Earnings - GuruFocus

May 14, 2025
pulisher
May 12, 2025

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025 - Eagle-Tribune

May 12, 2025
pulisher
May 07, 2025

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference - The Joplin Globe

May 07, 2025
pulisher
May 07, 2025

Market Highlights: Gossamer Bio Inc (GOSS) Ends on a Low Note at 1.09 - DWinneX

May 07, 2025
pulisher
May 05, 2025

Gossamer Bio Inc: Is GOSS Stock Worth Buying? - Stocksregister

May 05, 2025
pulisher
May 04, 2025

Gossamer Bio (GOSS) Expected to Announce Earnings on Tuesday - Defense World

May 04, 2025
pulisher
May 02, 2025

Gossamer Bio: Initiating Hold As Late‐Stage Data Nears Inflection (GOSS) - Seeking Alpha

May 02, 2025

Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.95
price up icon 1.40%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):